郑超湳 - 苏州大学 - 医学部药学院

个人简介

教育背景： 2001.09-2005.07学士药学专业中国药科大学药学基地班 2005.09-2010.07博士药物代谢动力学专业中国药科大学研究方向：以有效部位为结构单元的生脉方复杂组分代谢处置规律研究。工作经历： 2016.11-至今苏州大学药学院，讲师 2013.06-2016.04博士后Albrecht-Kossel神经再生研究所，罗斯托克大学，德国研究方向：基于 NPC1 蛋白（Niemann-Pick type C1）结构的 Niemann-Pick 罕见病的药物设计与筛选。 2013.02-2013.06博士后罗斯托克蛋白质组学中心，罗斯托克大学，德国研究方向：计算机模拟 KRAB 型锌指蛋白与转录中介因子 KAP-1 的RBCC 结构域的相互作用 2010.08-2011.02高级研究员，药物评价 II 室(DMPK)，上海医药集团中央研究院。负责领域：药物的代谢稳定性筛选和代谢物鉴定

研究领域

（1）儿童脑肿瘤特异靶点的探寻。（2）针对儿童脑肿瘤特异靶点的靶向药物设计、筛选和开发。（3）药物相互作用。

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Wang H, Dong Y, Zheng CN,* Sandoval CA, Makha M, Li YH,* Catalytic Cyanation Using CO2 and NH3, Chem2018 Dec; 4(12):2883-2893. 2.Bohl C, Pomorski A, Seemann S, Knospe AM, Zheng CN, Krężel A, Rolfs A, Lukas J.,Fluorescent probes for selective protein labeling in lysosomes: a case of α-galactosidase A.FASEB J.2017 Dec;31(12):5258-5267. 3.Trilck M, Peter F, Zheng CN, Frank M, Dobrenis K, Mascher H, Rolfs A, Frech M, Diverse manifestation of glycosphingolipid GM2 and cholesterol accumulations in NPC1 patient-specific iPSC-derived neurons carrying different NPC1 mutations.Brain Res. 2017 Feb 15;1657:52-61. 4.Lukas J, Pockrandt AM, Seemann S, Sharif M, Runge F, Pohlers S, Zheng CN, Gläser A, Beller M, Rolfs A, Giese AK, Enzyme enhancers for the treatment of fabry and pompe disease. Mol Ther.2015 Mar; 23(3):456-64. 5.Zheng CN, Hao HP, Wang X, Wu XL, Wang GJ, Sang GW, Liang Y, Xie L, Xia CH, Yao XL, Diagnosticfragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI-IT-TOF/MS: Shengmai injection as an example. J Mass Spectrom.2009 Feb; 44(2): 230-44. 6.Zheng CN, Hao HP, Wang GJ, Sang GW, Sun JG, Li P, Li J, Chiral separation of ibuprofen and chiralpharmacokinetics in healthy Chinese volunteers. EurJ Drug Metab Pharmacokinet.2008; 33(1): 45-51. 7.Hao HP, Zheng CN, Wang GJ, Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets. Acta Pharmaceutica Sinica. 200944(3): 270-5. 8.Hao HP, Cui N, Wang GJ, Xiang BR, Liang Y, Xu X, Zhang H, Yang J, Zheng CN, Wu L, Gong P, Wang W, Global detection and identification of nontarget components from herbal preparations by liquidchromatography hybrid ion trap time-of-flight mass spectrometry and a strategy. AnalChem.2008 Nov 1; 80(21): 8187-94. 9.Hao H, Lai L, Zheng C, Wang Q, Yu G, Zhou X, Wu L, Gong P, Wang G, Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship. Drug Metab Dispos.2010 Oct; 38(10):1731-9. 10.Lai L, Hao HP, Wang Q, Zheng CN, Zhou F, Liu YT, Wang YX, Yu G, Kang A, Peng Y, Wang GJ, Chen XJ, Effects of Short-term and Long-term Pretreatment of Schisandra Lignans on Regulating Hepatic and Intestinal CYP3A in Rats. Drug Metab Dispos.2009 Dec; 37(12):2399-407. 11.Lai L, Hao HP, Liu YT, Zheng CN, Wang Q, Wang GJ, Chen XJ, Characterization of pharmacokineticprofiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro. PlantaMed.2009 Jun; 75(8):797-802.